Media & events
Lyndra Named as Scrip Award Finalist in Two Categories
Happy to announce our ultra-long acting oral dosage form has been named a finalist for the Scrip MSD Innovation Award, and our co-founder Amy Schulman has been named a finalist in the Executive of the Year category!
Amy Schulman, Lyndra Co-founder and CEO, honored on 2019 PharmaVOICE 100
“Amy’s fearless approach to create durable value and change the trajectory of compliance for some of most difficult to treat diseases — Alzheimer’s disease, HIV, opioid use disorder, and schizophrenia — are just a couple of the reasons she has been identified as one of the 100 most inspiring people in the life-sciences industry,” says Taren Grom, editor, PharmaVOICE
Lyndra Presents @ BIO International
Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4
2019 BIO International